about
Advances and Challenges of Liposome Assisted Drug DeliveryUsing the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.Photoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive LiposomesLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.MR-guided focused ultrasound surgery, present and futureModel-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array.Intracranial dual-mode IVUS and hyperthermia using circular arrays: preliminary experimentsImaging and drug delivery using theranostic nanoparticlesTumor radiation response enhancement by acoustical stimulation of the vasculature.Dual-mode IVUS transducer for image-guided brain therapy: preliminary experimentsPhase-shift, stimuli-responsive drug carriers for targeted delivery.Novel Methods of Enhanced Retention in and Rapid, Targeted Release from Liposomes.Thermostability of biological systems: fundamentals, challenges, and quantification.Dual-mode IVUS catheter for intracranial image-guided hyperthermia: feasibility study.Controllable microfluidic synthesis of multiphase drug-carrying lipospheres for site-targeted therapyDual-mode intracranial catheter integrating 3D ultrasound imaging and hyperthermia for neuro-oncology: feasibility study.Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells.Ultrasound mediated delivery of drugs and genes to solid tumors.Non-invasive temperature mapping using temperature-responsive water saturation shift referencing (T-WASSR) MRIEnhanced efficacy of combination heat shock targeted polymer therapeutics with high intensity focused ultrasound.Comparison of one-dimensional and two-dimensional least-squares strain estimators for phased array displacement data.In vivo evaluation of small-molecule thermoresponsive anticancer drugs potentiated by hyperthermia.Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicThermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction.NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment.Magnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancerIncreasing the rate of heating: a potential therapeutic approach for achieving synergistic tumour killing in combined hyperthermia and chemotherapy.Fiberoptic microneedle device facilitates volumetric infusate dispersion during convection-enhanced delivery in the brain.Nanoparticle preconditioning for enhanced thermal therapies in cancerModel answers to lipid membrane questionsLipids, curvature, and nano-medicineThermal Assisted In Vivo Gene Electrotransfer.Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniquesCurrent status of antivascular therapy and targeted treatment in the clinic.Functional lipids and lipoplexes for improved gene delivery.Recent progress in tumor pH targeting nanotechnology.Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug deliveryTemperature sensitive peptides: engineering hyperthermia-directed therapeutics.Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.Thermoresponsive Collagen/Cell Penetrating Hybrid Peptide as Nanocarrier in Targeting-Free Cell Selection and Uptake.
P2860
Q26773160-537EA1E7-418B-48C9-849B-B17506539E85Q26784162-86F245D4-594C-4203-AB36-9FC0AD55B60AQ28553001-8499EFB0-8A52-4B24-A3FB-988E608508CAQ30366990-AF1DFB6F-844C-40D3-A25D-55043549ECB7Q30417756-580FD12E-E6BB-443C-BEFC-B20196BEC4D2Q30417816-E41C0618-06E2-4BF4-8D36-4FE2B77AD04CQ30447310-C9D361C3-8AE2-4084-9B7C-03600C8ED16FQ30449480-4A375060-4A1C-4F0E-AE3A-DD19B082B8B6Q30458925-96C3E8F5-6C1E-4718-A88E-A30194DF7C0FQ30463320-8FF71677-0222-4FE0-90DB-424AE466FC15Q30466278-9CCFF0EA-D08A-4F5D-96FD-56AB03213F9BQ30466993-E4C41BCF-27E8-4AAE-88ED-7E41E90149AAQ30474796-3494019C-DF41-45A7-805B-84A3CD687E1FQ30477609-38C6A3F8-AB1C-4E03-A756-9D6212302E99Q30480712-7BD3DAC9-7B24-42D9-BA4C-1736CA0DBAABQ30483904-FAA71F6B-6851-4ADB-ACCF-467D7F058B25Q30488487-6CD32E16-B822-44ED-9C38-237AD8D7DA1DQ30488681-D583E444-50FD-4A87-BAAB-7F97B26BA5BDQ30727212-96FDE3FA-6138-4321-B039-6347656287E2Q31146684-4D8CB94D-4315-47A7-AC36-E89E71381F40Q33464469-A2E0DA57-DEF6-4813-8AA9-D2FC4DA05D53Q33847893-FA148306-CC73-4858-A490-D14B3CDAD6E4Q33911056-C6A1420F-9FF9-4CD0-8258-8E54A9B0E0CEQ34061502-251B87AE-6D51-4C96-831C-567948DCFEC4Q34377146-D6B5E4FE-C6FA-4B38-B4EB-07B3B1A461EBQ34390068-74CA9607-B0DF-46B6-9B99-5995EDA16078Q34563822-7A801704-BAB2-491E-9CB5-520602F03126Q34824767-98FFA2E6-8B51-4F1E-A567-B60787556ADCQ34987068-1AD9AB80-63AD-4F68-8379-D7A442CB998FQ35234631-D8E51000-5A31-45C3-8F0D-96169DC003CEQ35590501-E110EE1F-18C9-4AD0-AB85-113BF2F492FBQ35974557-F0E66489-CCFF-4B8D-8A1B-27341D3A6740Q37063501-D34D346C-281F-4820-A288-891C074B991FQ37063510-9B41FB17-34CD-4A6D-A8CC-746CC8D7FA17Q37166374-4A5B608A-BFB3-4A75-A12D-ACD8C7AFEBBFQ37197375-06A01F74-F42D-43FB-9E60-33F8A477DE2CQ37207271-AA0639DB-4AA3-4A73-9060-71B2E3AE5504Q37209904-AE805EF5-6B9C-4711-9FA5-96363E9D069BQ37314628-AEC40D4A-FCBD-4BDF-B3D2-641178339818Q37525095-5F214C99-D9B9-4127-B4BF-544D9632B443
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Hyperthermia mediated liposomal drug delivery.
@en
Hyperthermia mediated liposomal drug delivery.
@nl
type
label
Hyperthermia mediated liposomal drug delivery.
@en
Hyperthermia mediated liposomal drug delivery.
@nl
prefLabel
Hyperthermia mediated liposomal drug delivery.
@en
Hyperthermia mediated liposomal drug delivery.
@nl
P2093
P2860
P1476
Hyperthermia mediated liposomal drug delivery.
@en
P2093
Ana M Ponce
David Needham
Mark W Dewhirst
Zeljko Vujaskovic
P2860
P304
P356
10.1080/02656730600582956
P577
2006-05-01T00:00:00Z